The use of mechanistic biomarkers for evaluating investigational CNS compounds in early drug development. [electronic resource]
- Current opinion in investigational drugs (London, England : 2000) Jul 2010
- 795-801 p. digital
Publication Type: Journal Article; Review
2040-3429
Animals Biomarkers, Pharmacological--metabolism Central Nervous System Agents--pharmacology Clinical Trials, Phase I as Topic--methods Clinical Trials, Phase II as Topic--methods Drug Discovery--methods Humans Positron-Emission Tomography--methods Translational Research, Biomedical--methods